Search results
Pages
-
- Hospital transfer after a breast cancer diagnosis: A population-based study in the Netherlands of the extent, predictive characteristics and its impact on time to treatment
-
- Hypothyroidism and the risk of breast cancer recurrence and all-cause mortality - a Danish population-based study
-
- The prognostic value of tumour-stroma ratio in primary breast cancer with special attention to triple-negative tumours: a review
-
- Treatment strategies and survival outcomes in older women with breast cancer: A comparative study between the FOCUS cohort and Nottingham cohort
-
- Shared decision-making about treatments for early breast cancer : preferences of older patients and clinicians
-
- Adjuvant dose-dense doxorubicin-cyclophosphamide versus docetaxel-doxorubicin-cyclophosphamide for high-risk breast cancer: First results of the randomised MATADOR trial (BOOG 2004-04)
-
- Holding the balance; the equilibrium between ERα-activation, epigenetic alterations and chromatin integrity
-
- Exploration of tumour-infiltrating lymphocytes as a predictive biomarker for adjuvant endocrine therapy in early breast cancer
-
- Reliability of Self-reported Treatment Data by Patients With Breast Cancer Compared With Medical Record Data
-
- The clinical impact of molecular breast imaging in women with proven invasive breast cancer scheduled for breast-conserving surgery
-
- Treatment decisions and the impact of adverse events before and during extended endocrine therapy in postmenopausal early breast cancer
-
- Prognostic value of tumor-stroma ratio combined with the immune status of tumors in invasive breast carcinoma
-
- A prospective comparison of younger and older patients' preferences for breast-conserving surgery versus mastectomy in early breast cancer
-
- The association of diabetes mellitus and insulin treatment with expression of insulin-related proteins in breast tumors
-
- Single-nucleotide polymorphisms in the genes of CES2, CDA and enzymatic activity of CDA for prediction of the efficacy of capecitabine-containing chemotherapy in patients with metastatic breast cancer